Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Targeting ornithine decarboxylase can help prevent skin cancer.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Tofacitinib may effectively treat folliculitis decalvans.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Fernblock® helps protect skin cells from pollution and stress, reducing inflammation and damage.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Nostoc verrucosum extracts may help reduce melanin production and have antioxidant properties.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

Alternating treatment with two drugs could help cells in a rapid aging disease.

Neuropilin 2 may be a biomarker for melanoma and affects melanocyte behavior.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Topical Ruxolitinib may safely treat severe hair loss.

Upadacitinib may cause hair loss.

Verteporfin may improve hair regrowth and reduce scarring after hair transplants.

Temozolomide improves survival in grade III glioma patients without harming quality of life.